Microalbuminuria (or urinary albumin excretion rates (AER) above normal limits) is associated with coronary heart disease (CHD) particularly in diabetics. To determine the sensitivity and specificity of AER for CHD in a non-diabetic population we prospectively studied 115 consecutive patients undergoing coronary angiography and 66 undergoing exercise electrocardiography (ECG). There was no relationship between AER and the severity of CHD determined by angiography (Gensini-scored). While microalbuminuria (AER>20 fg/minute) was 91% specific it had low sensitivity (12%). Microalbuminuria is not a sensitive indicator of CHD in a non-diabetic population.
Introduction
Increasing evidence suggests that microalbuminuria excretion of abnormal levels of urinary albumin, undetectable by reagent strips, usually expressed as albumin excretion rate (AER) is of pathological significance. It is strongly prognostic of renal failure, proliferative retinopathy and cardiovascular mortality in patients with insulindependent and non-insulin-dependent (NIDDM) diabetes mellitus. '17 Recently, an association between microalbuminuria and all causes of mortality in non-diabetic subjects has also been demonstrated.8 '9 In the Islington Diabetes Survey, Yudkin et al.'0 reported that microalbuminuria was a predictor of coronary heart disease (CHD) in non-diabetic subjects.
This study was undertaken to examine the strength of the suggested association between microalbuminuria and CHD in a cross-section of non-diabetic patients with angiographically or exercise electrocardiographically proven CHD, particularly to determine if it is predictive of the severity of coronary ischaemia.
Subjects and methods
A timed overnight urine collection was obtained from 115 consecutive, non-diabetic (normal fasting glucose) patients (age 57 ± 10 years, 95 male), undergoing coronary angiography. A midstream urine was examined to exclude urinary tract infection as a cause of microalbuminuria. Time of bladder voiding before retiring was noted. All nocturia and first-morning urine was collected.
Total volume and collection time were noted.
Samples were Dipstix-tested (Ames Division, Miles Lab.) to rule out gross proteinuria and haematuria, and 61 were randomly neutralized to pH = 7 before being frozen at -18C. They were assayed within 4 months using an immunoturbidimetric assay, -'3 coefficient of variation (CV) = 3.5% and 6.3% at 5 mg/l and 80 mg/l, respectively. Forty-four random samples were also analysed by radioimmunoassay,'4 CV = 2.7% and 3.9% at 5 and 80 mg/l, respectively and there was a highly significant correlation (r = 0.98) between these two methods.
A distinct group of 63 consecutive patients (age 55 ± 9.5 years, mean ± s.d., 43 males) gave random urine samples before and after exercise electrocardiogram (ECG). The bladder was emptied before exercise, and a modified Bruce Protocol used. No fluid was allowed prior to taking the post-exercise sample, as forced diuresis may interfere with true AER. '5 Major cardiovascular risk factors were assessed on all patients. Hypertension was defined as blood pressure > 150/90 mmHg. Fasting total cholesterol, blood glucose, past and current smoking history, family history of coronary heart disease and current drug therapies were noted. Cineangiography was analysed by a radiologist, blinded to the other results, according to the Gensini Score. ' Subjects with microalbuminuria (AER > 20 fLg/ minute), were compared to those with normal levels (n = 102). These groups (Table I) were well matched for age, sex, current treatment regimens, body-mass index (BMI) and proportion of smokers. Serum creatinine levels were higher in the higher AER group but there was no association with CHD, blood pressure or cholesterol history nor family history of CHD. Diabetes Survey may have recorded a spuriously high prevalence of CHD by using the WHO questionnaire to define CHD, relying in some cases on subjects' own history of angina or myocardial infarction, as chest pain frequently is falsely positive for CHD even ifguided by WHO criteria. '9 Secondly, subjects in the population screening study were not examined for asymptomatic urinary tract infection. Thirdly, subjects with CHD were significantly older than those deemed free of CHD.
Subsequently, Damsgaard et al. '8 showed an association between AER and overall mortality in elderly non-diabetic subjects (aged 60-74 years). It is therefore possible that the association between AER and CHD reported by Yudkin et al. may in part reflect an age effect.
The Islington Diabetes Survey population was also significantly biased on the basis of selfselection as 45% of those with CHD had impaired glucose tolerance or frank diabetes, compared with 25% of the group without CHD.'0 In addition, both systolic and diastolic blood pressure was significantly higher in those with CHD and as hypertension is associated with microalbuminuria,20 this may also be contributory.
There is increasing evidence that patients with insulin resistance and hypertension are more likely to have microalbuminuria than those with normal glucose tolerance and systemic blood pressure. "22 Glucose intolerance with hyperinsulinaemia may be a common denominator in the associated subgroup of patients with NIDDM, hyperlipidaemia, hypertension and microalbuminuria. Since our population excluded patients with diabetes, the association of AER with coronary heart disease in earlier studies may be explained in part through diabetes and glucose intolerance.
We confirmed Damsgaard's association of AER with serum creatinine noting a strong association between CHD and serum creatinine. Damsgaard also reported that creatinine predicted mortality and that heart disease was the commonest cause.18
There was a particularly strong association between family history of CHD and angiographic evidence of CHD. The strength of this association may be influenced by relatives themselves having risk factors for CHD such as excessive smoking, hypertension, hypercholesterolaemia, but we have not studied this.
Our exercise study confirms the postexertional increment in microalbuminuria;15,23 however, no pattern between the level of increase and result of the exercise test was noted. Neither was exertional microalbuminuria related to the level of physical activity achieved on the modified Bruce Protocol. It has been shown that angiotensin converting enzyme inhibitors reduce resting and exerciseinduced microalbuminuria.2425 Perhaps individual differences in intraglomerular haemodynamics during exercise determines the degree of postexertional microalbuminuria which may be mediated by renal prostaglandins.26
In conclusion, we were unable to find an association between AER levels and established CHD. While there is evidence from other community studies that AER may be an indicator of overall mortality in older subjects over 60 years, this may reflect rising systolic blood pressure and glucose intolerance in the elderly. The value of AER as an independent specific marker of CHD in the younger non-diabetic patient population is not established.
